openPR Logo
Press release

Metabolic Testing Market Opportunity Analysis, 2018-2026

08-09-2018 03:41 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Metabolic Testing Market Opportunity Analysis, 2018-2026

Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease condition such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. Metabolic syndrome is a group of metabolic disorders such as high blood pressure with high fasting glucose levels and abnormal obesity. Metabolism pattern and metabolic capacity is determined with the help of metabolic testing for management of such conditions. Metabolism is a chemical reaction occurring in the body to maintain the standard state of the organism or body. In case of sports professionals, the metabolic testing is done in order to test body’s ability of oxygen consumption. Technologies involved in metabolic testing include VO2 Max analysis, RMR analysis, and body composition analysis. VO2 Max analysis includes body’s maximum rate of oxygen consumption measured during incremental exercise.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1652

RMR analysis is resting metabolic rate analysis in which measurement of food, and energy required to maintain basic body functions such as heartbeat, breathing, and maintenance of body heat is done. Moreover, body composition analysis consists of determination of ratio of different tissues of the body. Metabolic testing is helpful in lifestyle disease management, performance testing for sports and fitness professionals, and in case of metabolic disorders such as diabetes. Products available in the market work on either of these technologies such as RMR, VO2 Max, and body consumption analysis. Commercially available products for metabolic testing include ReeVue, Quark RMR w/CPET, Quark CPET, K5, and Ultima CardiO2.

Metabolic Testing Market Drivers

Metabolic testing market is expected to witness significant growth over the forecast period, owing to rising prevalence of lifestyle diseases. Prevalence of cardiovascular diseases, obesity, and type 2 diabetes is rising, globally. For instance, according to the World Health Organization (WHO), around 17 million people die annually from cardiovascular diseases. According to American Diabetes Association (ADA), in 2015, 30.3 million in the U.S. were suffering from diabetes. Prevalence of lifestyle diseases is expected to increase over the forecast period in turn fostering growth of the global metabolic testing market. Manufacturers are focusing on development of technologically advanced metabolic rate testing equipment to stay ahead in the competition. For instance, in March 2018 Cosmed launched Q-NRG, a metabolic monitor for energy expenditure measurements in ventilated patients in the ICU.

Moreover, Cosmed received innovative technology designation from Vizient, Inc. for its K5 Wearable Metabolic System, in 2017. Manufacturers are focusing on participating in trade fairs and in extensive product promotion, in order to increase the awareness of the metabolic testing. For instance, Geratherm Medical AG and Cosmed srl participated in World Forum for Medicine, MEDICA 2017. Increasing awareness towards metabolic testing is expected to boost growth of the metabolic testing market over the forecast period.

However, low awareness (despite manufacturer’s attempts to increase awareness) regarding metabolic testing, high costs of the products, and comparatively less market penetration of the products is expected to restrain growth of the metabolic testing market over the forecast period.

Metabolic Testing Market Insights

On the basis of region, North America and Europe are expected to exhibit significant growth in the metabolic testing market over the forecast period. This is owing to high presence of leading manufacturers who offer products in this category, in North America. Manufacturers such as General Electric Company and OSI Systems, Inc. offer products in this category that have high presence in the region. Prevalence of lifestyle diseases as well as obesity issues are fairly high in these regions leading to metabolic diseases. For instance, according to Center for Disease Control and Prevention (CDC), more than 1/3rd of U.S. adults had obesity in 2014. Metabolic testing is gradually gaining traction in emerging economies such as Asia Pacific. Manufacturers such as Cosmed srl offer products in these regions through distributors. For instance, TBS India, partnered with Cosmed Italy and offers products sold by Cosmed in India.

Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/1652

Metabolic Testing Market - Competitive Analysis

Key players operating in the metabolic testing market include COSMED srl, CareFusion Corporation, Geratherm Medical AG, MGC Diagnostics Corporation, General Electric Company, CORTEX Biophysik GmbH, Microlife Medical Home Solutions, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., and OSI Systems, Inc.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolic Testing Market Opportunity Analysis, 2018-2026 here

News-ID: 1171321 • Views:

More Releases from Coherent Market Insights

Pleural Diseases Market Exclusive Report with Detailed Study Analysis | Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc
Pleural Diseases Market Exclusive Report with Detailed Study Analysis | Bristol …
The latest Pleural Diseases Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The Industry compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future.
Neuroregeneration Therapy Market Know the Scope and Trends | Biogen Inc., AstraZeneca PLC, Pfizer Inc., Novartis International AG
Neuroregeneration Therapy Market Know the Scope and Trends | Biogen Inc., AstraZ …
The latest Neuroregeneration Therapy Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The Industry compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future.
Cancer Immunotherapy Market to Reflect Significant Incremental Opportunity During 2025-2032| Gilead Sciences, Inc., Johnson & Johnson, Actym Therapeutics, Inc
Cancer Immunotherapy Market to Reflect Significant Incremental Opportunity Durin …
The latest Cancer Immunotherapy Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The Industry compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future.
U.S. Nasal Spray Market Future Business Opportunities 2025-2032 | Sanofi, GSK plc., Merck & Co., Inc., Novartis AG, Pfizer Inc
U.S. Nasal Spray Market Future Business Opportunities 2025-2032 | Sanofi, GSK pl …
U.S. nasal spray market is estimated to be valued at USD 11.16 Bn in 2025 and is expected to reach USD 18.05 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032. The latest U.S. Nasal Spray Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It

All 5 Releases


More Releases for Metabolic

Comprehensive Metabolic Panel Testing Market Size
The findings reviewed by GME stated that the Global Comprehensive Metabolic Panel Testing Market will grow from USD 11.5 billion in 2021, to USD 13.8 billion in 2026 with a CAGR value of 7.5%. Factors like the rising prevalence of chronic diseases, increasing prevalence of Covid-19 and increasing patients, technological advancements, increasing disposable income, growing geriatric population, emphasis on early diagnosis and treatment are expected to support the growth of
Therapeutic Proteins for Metabolic Disorders Treatment Market is Driven by Incre …
Therapeutic Proteins for Metabolic Disorders Treatment Market: Introduction Therapeutic proteins are proteins which are engineered in a laboratory for pharmaceutical use. Therapeutic proteins are used as a personalized treatment approach which supports a precisely targeted therapeutic process by making up for the deficiency of an essential protein. Therapeutic proteins are deliberately adjusted to increase their clinical potential which is followed by enhancements derived from protein or glycol engineering, Fc fusion, or conjugation
Inherited Metabolic Disorders Market Comprehensive Survey 2025
Global Inherited Metabolic Disorders Market: Overview Globally, IMD affects nearly one in every 2,500 to 5,000 individuals with nearly 300 to 600 new cases found in the U.K., according to Public Health Genetics U.K. The specificity and high risk affinity of IMD varies from disorder to disorder, with some disorders like familial cylomicronemia being closely associated with Caucasians and others like porphyria being recoded largely among African Americans. These metabolic
Inherited Metabolic Disorders Market Felicitous over 2025
Global Inherited Metabolic Disorders (IMD) Market: Snapshot Inherited metabolic disorders (IMD), as the name suggests, are genetic conditions resulting in metabolism issues. The root cause behind maximum cases of inherited metabolic disorders (IMD) is a gene mutation that probably happened a lot many generations back. The mutation in the gene is carried through the generations. Treatment of inherited metabolic disorders (IMD) consists of dietary supplementation, dietary restrictions, drugs that thwart or regulate
Inherited Metabolic Disorders Market Current Trends by 2025
Global Inherited Metabolic Disorders (IMD) Market: Snapshot Inherited metabolic disorders (IMD), as the name suggests, are genetic conditions resulting in metabolism issues. The root cause behind maximum cases of inherited metabolic disorders (IMD) is a gene mutation that probably happened a lot many generations back. The mutation in the gene is carried through the generations. Treatment of inherited metabolic disorders (IMD) consists of dietary supplementation, dietary restrictions, drugs that thwart or regulate
Metabolic Testing Market: In-Depth Market Research Report
Metabolism is a chemical reaction and physical process that involves maintenance of the living state, such as breathing, blood circulation, contraction of muscles, digestion of food and nutrients, elimination of wastes such as urine, controlling body temperature, and functioning of brain and nerves of the organism. It is a pathway that begins with a sequence of chemical reactions with a specific molecule and ends with a product with the help